1
/
of
1
Elabscience
SKU:PKSH032082
Recombinant Human Apolipoprotein A-I/ApoAI Protein
Recombinant Human Apolipoprotein A-I/ApoAI Protein
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human Apolipoprotein A-I/ApoAI Protein, a cutting-edge product meticulously engineered to revolutionize the field of lipid metabolism research. This exceptional protein, derived from advanced recombinant technology, showcases unparalleled purity and functionality, making it an indispensable tool for scientists and researchers alike.
Crafted with utmost precision, our Recombinant Human Apolipoprotein A-I/ApoAI Protein exhibits remarkable structural integrity, closely resembling its native counterpart. This fidelity ensures accurate and reliable results, enabling comprehensive investigations into the intricate mechanisms governing lipid metabolism and associated disorders.
With its exceptional purity, this protein offers an unrivaled advantage in experimental settings, guaranteeing minimal interference and optimal performance. Its high solubility and stability further enhance its usability, facilitating seamless integration into a wide range of experimental protocols.
The Recombinant Human Apolipoprotein A-I/ApoAI Protein's versatility extends beyond its exceptional quality. It serves as an invaluable tool for elucidating the intricate interplay between apolipoprotein A-I and various lipid components, enabling a deeper understanding of their roles in cardiovascular health, atherosclerosis, and other lipid-related disorders.
Furthermore, this product's compatibility with various analytical techniques, such as mass spectrometry and nuclear magnetic resonance, empowers researchers to explore the dynamic interactions between apolipoprotein A-I and lipids at a molecular level, unraveling novel insights into lipid metabolism regulation.
In summary, the Recombinant Human Apolipoprotein A-I/ApoAI Protein stands as a pinnacle of scientific innovation, offering researchers an unparalleled resource to unravel the complexities of lipid metabolism. Its exceptional purity, structural fidelity, and compatibility with diverse experimental techniques make it an indispensable asset in advancing our understanding of lipid-related disorders and paving the way for novel therapeutic interventions.
Crafted with utmost precision, our Recombinant Human Apolipoprotein A-I/ApoAI Protein exhibits remarkable structural integrity, closely resembling its native counterpart. This fidelity ensures accurate and reliable results, enabling comprehensive investigations into the intricate mechanisms governing lipid metabolism and associated disorders.
With its exceptional purity, this protein offers an unrivaled advantage in experimental settings, guaranteeing minimal interference and optimal performance. Its high solubility and stability further enhance its usability, facilitating seamless integration into a wide range of experimental protocols.
The Recombinant Human Apolipoprotein A-I/ApoAI Protein's versatility extends beyond its exceptional quality. It serves as an invaluable tool for elucidating the intricate interplay between apolipoprotein A-I and various lipid components, enabling a deeper understanding of their roles in cardiovascular health, atherosclerosis, and other lipid-related disorders.
Furthermore, this product's compatibility with various analytical techniques, such as mass spectrometry and nuclear magnetic resonance, empowers researchers to explore the dynamic interactions between apolipoprotein A-I and lipids at a molecular level, unraveling novel insights into lipid metabolism regulation.
In summary, the Recombinant Human Apolipoprotein A-I/ApoAI Protein stands as a pinnacle of scientific innovation, offering researchers an unparalleled resource to unravel the complexities of lipid metabolism. Its exceptional purity, structural fidelity, and compatibility with diverse experimental techniques make it an indispensable asset in advancing our understanding of lipid-related disorders and paving the way for novel therapeutic interventions.
Share
